148 related articles for article (PubMed ID: 3435596)
1. Cardiovascular effects of three calcium entry blockers in conscious dogs.
Eigenmann R; Gerold M
Arzneimittelforschung; 1987 Sep; 37(9):1020-5. PubMed ID: 3435596
[TBL] [Abstract][Full Text] [Related]
2. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade.
Warltier DC; Zyvoloski MG; Gross GJ; Brooks HL
J Pharmacol Exp Ther; 1984 Aug; 230(2):367-75. PubMed ID: 6146711
[TBL] [Abstract][Full Text] [Related]
3. [Calcium antagonists: effect on peripheral and coronary hemodynamics].
Simon R
Z Kardiol; 1984; 73 Suppl 2():79-88. PubMed ID: 6528705
[TBL] [Abstract][Full Text] [Related]
4. Tiapamil, a new calcium antagonist. 1. Demonstration of calcium antagonistic activity and related studies.
Eigenmann R; Blaber L; Nakamura K; Thorens S; Haeusler G
Arzneimittelforschung; 1981; 31(9):1393-401. PubMed ID: 7197945
[TBL] [Abstract][Full Text] [Related]
5. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
[TBL] [Abstract][Full Text] [Related]
6. Comparison of cardiovascular, renal, and humoral effects of acute administration of two calcium channel blockers in normotensive and hypertensive subjects.
Leonetti G; Cuspidi C; Sampieri L; Terzoli L; Zanchetti A
J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S319-24. PubMed ID: 6184561
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular effects of OPC-13340, a potent, long-acting 1,4-dihydropyridine calcium channel blocker, in dogs.
Mori T; Nakayama N; Ohura M; Ikezono K; Kinoshita S; Kamata M; Hosokawa T; Yamashita S; Yabuuchi Y
Arch Int Pharmacodyn Ther; 1993; 321():41-56. PubMed ID: 8323415
[TBL] [Abstract][Full Text] [Related]
8. Comparison of vasodilating effects of nisoldipine and nifedipine in anesthetized open-chest dogs.
Sakanashi M; Noguchi K; Kato T; Sunagawa R; Nagamine F; Nakasone J
Arzneimittelforschung; 1986 Dec; 36(12):1736-9. PubMed ID: 3566835
[TBL] [Abstract][Full Text] [Related]
9. Chronic administration of tiapamil prevents hemodynamic alterations accompanying development of high blood pressure in hypertensive rats.
Hefti F; Gerold M; Holck M
J Cardiovasc Pharmacol; 1984; 6(6):1192-200. PubMed ID: 6084779
[TBL] [Abstract][Full Text] [Related]
10. Effects of E4080, a novel bradycardic agent with a coronary vasodilating property, on coronary and systemic hemodynamics in conscious dogs.
Adachi H
J Pharmacol Exp Ther; 1994 Jan; 268(1):133-8. PubMed ID: 8301548
[TBL] [Abstract][Full Text] [Related]
11. Effect of a new calcium antagonist, nitrendipine, on blood pressure and heart rate of conscious, unrestrained dogs.
Knorr A; Stoepel K
Arzneimittelforschung; 1981; 31(12):2062-4. PubMed ID: 7199298
[TBL] [Abstract][Full Text] [Related]
12. Comparative effects of verapamil, tiapamil, diltiazem and nifedipine on systemic and splanchnic hemodynamics in man.
Gasic S; Eichler HG; Korn A
Int J Clin Pharmacol Ther Toxicol; 1987 Sep; 25(9):498-503. PubMed ID: 3679621
[TBL] [Abstract][Full Text] [Related]
13. Differential cardiovascular effects of calcium channel blocking agents: potential mechanisms.
Millard RW; Lathrop DA; Grupp G; Ashraf M; Grupp IL; Schwartz A
Am J Cardiol; 1982 Feb; 49(3):499-506. PubMed ID: 6277175
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular profile of RWJ 29009, a new potassium channel activator, in anesthetized and conscious dogs.
Damiano BP; Giardino EC; Haertlein BJ; Stump GL; Mitchell JA; Falotico R
J Cardiovasc Pharmacol; 1994 Feb; 23(2):300-10. PubMed ID: 7511761
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular effects of a novel vasoactive antihypertensive agent, Ro 12-4713.
Gerold M; Eigenmann R; Hefti F; Daum A; Haeusler G
J Pharmacol Exp Ther; 1981 Mar; 216(3):624-33. PubMed ID: 7009831
[TBL] [Abstract][Full Text] [Related]
16. [Vasodilator effects of LF 2.0254, a new 1,4-dihydropyridine. Comparison with nifedipine].
Pruneau D; Roy F; Brown NL
Therapie; 1989; 44(3):203-8. PubMed ID: 2781506
[TBL] [Abstract][Full Text] [Related]
17. Vasodilator action of KB-944, a new calcium antagonist.
Morita T; Yoshino K; Kanazawa T; Ito K; Nose T
Arzneimittelforschung; 1982; 32(9):1037-42. PubMed ID: 6890822
[TBL] [Abstract][Full Text] [Related]
18. Nisoldipine (BAY K 5552), a new calcium antagonist. Antihypertensive effect in conscious, unrestrained renal hypertensive dogs.
Knorr A
Arch Int Pharmacodyn Ther; 1982 Nov; 260(1):141-50. PubMed ID: 7165419
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular effects of tiapamil (Ro 11-1781), a new calcium-entry blocker.
Gerold M; Eigenmann R; Haeusler G
J Cardiovasc Pharmacol; 1982; 4(3):419-29. PubMed ID: 6177938
[TBL] [Abstract][Full Text] [Related]
20. Regional vasodilating and cardiac effects of nicardipine in anaesthetized open chest dog.
Bongrani S; Razzetti R; Schiantarelli P
Arch Int Pharmacodyn Ther; 1985 Feb; 273(2):226-36. PubMed ID: 4004418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
